Landmark SINGLE-AF Trial Demonstrates Significant Cardiovascular Benefits of DOACs for Intermediate-Risk Atrial Fibrillation Patients
A major clinical trial has provided long-awaited clarity for the management of atrial fibrillation (AF) in patients previously caught in a clinical "gray area." Results from the SINGLE-AF study, presented…
